Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID: FERMENTA
  • BSEID: 506414
INR
328.55
1.05 (0.32%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 34.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
525.43
469.48
335.66
349.94
398.52
377.29
292.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
525.43
469.48
335.66
349.94
398.52
377.29
292.95
Raw Material Cost
148.76
129.95
77.00
112.02
132.19
141.95
105.61
Purchase of Finished goods
43.64
59.66
27.02
19.02
14.70
21.17
0.50
(Increase) / Decrease In Stocks
-0.47
-31.16
26.11
22.51
6.27
-28.75
-27.09
Employee Cost
82.59
65.10
58.55
57.91
62.97
58.22
50.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
2.12
7.68
19.14
Other Expenses
151.07
136.14
119.46
120.54
118.81
95.35
89.56
Total Expenditure (Excl Depreciation)
425.59
359.68
308.15
332.00
337.06
295.62
237.76
Operating Profit (PBDIT) excl Other Income
99.84
109.80
27.51
17.94
61.46
81.67
55.19
Other Income
22.39
11.82
11.81
7.69
8.14
8.25
12.32
Operating Profit (PBDIT)
122.23
121.62
39.32
25.63
69.60
89.92
67.51
Interest
11.54
14.19
17.05
20.78
17.08
17.97
9.09
Exceptional Items
6.88
0.00
-7.43
-28.48
0.00
0.00
0.00
Gross Profit (PBDT)
117.57
107.43
14.84
-23.63
52.52
71.95
58.42
Depreciation
21.70
24.22
24.72
28.25
25.56
20.31
15.00
Profit Before Tax
95.86
83.21
-9.87
-51.87
26.94
51.63
43.42
Tax
25.61
6.81
14.14
1.68
11.88
9.10
-16.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
70.25
76.40
-24.01
-53.55
15.06
42.53
59.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
70.25
76.40
-24.01
-53.55
15.06
42.53
59.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.51
0.46
0.95
2.06
0.39
2.98
0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
71.77
76.86
-23.06
-51.50
15.45
45.51
59.53
Equity Capital
14.34
14.58
14.44
14.43
14.42
14.42
14.42
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
391.88
348.09
274.42
300.21
357.71
346.17
295.01
Earnings per share (EPS)
25.02
26.36
-7.98
-17.84
5.36
15.78
20.64
Diluted Earnings per share
24.51
26.35
-5.42
-17.85
5.33
15.69
20.53
Operating Profit Margin (Excl OI)
19.0%
23.39%
8.2%
5.13%
15.42%
21.65%
18.84%
Gross Profit Margin
22.38%
22.88%
4.42%
-6.75%
13.18%
19.07%
19.94%
PAT Margin
13.37%
16.27%
-7.15%
-15.3%
3.78%
11.27%
20.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 11.92% vs 39.87% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -6.62% vs 433.30% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -9.07% vs 299.13% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -18.68% vs -16.77% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Fermenta Biotec. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
525.43
0
525.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
525.43
0
525.43
Raw Material Cost
148.76
0
148.76
Purchase of Finished goods
43.64
0
43.64
(Increase) / Decrease In Stocks
-0.47
0
-0.47
Employee Cost
82.59
0
82.59
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
151.07
0.00
151.07
Total Expenditure (Excl Depreciation)
425.59
0
425.59
Operating Profit (PBDIT) excl Other Income
99.84
0.00
99.84
Other Income
22.39
0
22.39
Operating Profit (PBDIT)
122.23
0
122.23
Interest
11.54
0
11.54
Exceptional Items
6.88
0
6.88
Gross Profit (PBDT)
117.57
0
117.57
Depreciation
21.70
0
21.70
Profit Before Tax
95.86
0
95.86
Tax
25.61
0
25.61
Provisions and contingencies
0.00
0
0.00
Profit After Tax
70.25
0
70.25
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
70.25
0
70.25
Share in Profit of Associates
0.00
0
0.00
Minority Interest
1.51
0
1.51
Other related items
0.00
0.00
0.00
Consolidated Net Profit
71.77
0
71.77
Equity Capital
14.34
0
14.34
Face Value
5.00
0
0.00
Reserves
391.88
0
391.88
Earnings per share (EPS)
25.02
0
25.02
Diluted Earnings per share
24.51
0
24.51
Operating Profit Margin (Excl OI)
19.00%
0%
0.00
19.00%
Gross Profit Margin
22.38%
0%
0.00
22.38%
PAT Margin
13.37%
0%
0.00
13.37%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 525.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.92% vs 39.87% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 71.77 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -6.62% vs 433.30% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 99.84 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -9.07% vs 299.13% in Mar 2025

Annual - Interest
Interest 11.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -18.68% vs -16.77% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.00%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025